Bookbuilding IPO | ₹[.] Cr | Listing at BSE, NSE |
Ujin Pharma Ltd. has filed a Draft Red Herring Prospectus (DRHP) with SEBI on June 22, 2026 to raise funds through Initial Public Offer (IPO).
Ujin Pharma Ltd. IPO is a Book Build Issue of 1.92 crore equity shares consisting of a fresh issue of upto 1.19 crore equity shares and an offer for sale (OFS) of upto 0.73 crore equity shares.
The equity shares are proposed to be listed on NSE and BSE. SMC Capitals Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. Key details like IPO dates, IPO price bands and lot size are yet to be announced.
Refer to Ujin Pharma IPO DRHP for more details.
| IPO Date | [.] |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | |
| Lot Size | |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 1,91,51,400 shares (agg. up to ₹[.] Cr) |
| Fresh Issue | 1,18,69,100 shares (agg. up to ₹[.] Cr) |
| Offer for Sale | 72,82,300 shares of ₹10 (agg. up to ₹[.] Cr) |
| Share Holding Pre Issue | 5,50,00,000 shares |
| Share Holding Post Issue | 6,68,69,100 shares |
| Description | Date |
|---|---|
| Filed with SEBI/Exchange | Mon, Jun 22, 2026 |
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Offer |
| Retail Shares Offered | Not less than 35% of the Net Offer |
| NII Shares Offered | Not less than 15% of the Net Offer |
Incorporated in May 2024, Ujin Pharma Limited is a chemical distribution and supply company engaged in the trading and distribution of solvents, specialty chemicals, acids, monomers, pharmaceutical raw materials, and nutraceuticals. The company serves a diverse customer base across pharmaceuticals, agrochemicals, specialty chemicals, petrochemicals, automotive, paints & coatings, printing inks, packaging, and industrial sectors.
With over two decades of industry experience through its predecessor partnership firm, the company has built a strong sourcing network comprising 1,277 suppliers and distribution infrastructure supported by warehouses in Bhiwandi (Maharashtra) and Kandla (Gujarat). During the last three financial years and the period ended December 31, 2025, the company supplied approximately 8.53 lakh MT of chemical products to over 3,000 customers.
Through its subsidiary, Shiv Shakti Oxalate Private Limited (SSOPL), the company has expanded into value-added chemical processing activities including solvent recycling, solvent recovery, and printing chemical manufacturing. SSOPL operates a manufacturing facility at Kurkumbh, Pune, equipped with distillation, extraction, blending, storage, and laboratory testing facilities.
As of March 31, 2026, the company had 73 employees across management, finance, operations, logistics, sales, compliance, production, quality, and safety functions.
Key Strengths
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 699.31 | 615.82 | 483.50 | 395.67 |
| Total Income | 1,523.11 | 1,636.06 | 1,497.33 | 1,435.20 |
| Profit After Tax | 25.47 | 14.29 | 16.01 | 10.04 |
| EBITDA | 39.97 | 35.45 | 29.62 | 13.09 |
| NET Worth | 157.76 | 132.29 | 108.58 | 93.32 |
| Reserves and Surplus | 138.65 | 114.52 | 108.58 | 93.32 |
| Total Borrowing | 244.21 | 207.68 | 147.22 | 62.01 |
| Amount in ₹ Crore | ||||
| Company | Issue Type | Issue Size | Issue Price | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|
| Sudeep Pharma Ltd. | Mainboard | ₹895.00 Cr | ₹593 | ₹774.15 | +30.55% | ₹809.20 (-4.90%) |
| Gem Aromatics Ltd. | Mainboard | ₹451.25 Cr | ₹325 | ₹319.05 | -1.83% | ₹184.83 (+1.88%) |
| Vahh Chemicals Ltd. | SME | ₹13.45 Cr | ₹60 | ₹66.50 | +10.83% | ₹60.55 (-5.80%) |
| Biopol Chemicals Ltd. | SME | ₹31.26 Cr | ₹108 | ₹105.50 | -2.31% | ₹93.75 (+1.24%) |
| Neochem Bio Solutions Ltd. | SME | ₹44.97 Cr | ₹98 | ₹111.80 | +14.08% | ₹104.00 (-1.89%) |
| Speb Adhesives Ltd. | SME | ₹33.73 Cr | ₹56 | ₹57.00 | +1.79% | ₹86.95 (+2.29%) |
| SK Minerals & Additives Ltd. | SME | ₹41.15 Cr | ₹127 | ₹152.25 | +19.88% | ₹377.00 (+5.00%) |
| Shlokka Dyes Ltd. | SME | ₹57.79 Cr | ₹91 | ₹85.50 | -6.04% | ₹25.00 (+0.00%) |
| Snehaa Organics Ltd. | SME | ₹32.68 Cr | ₹122 | ₹115.90 | -5.00% | ₹44.00 (+3.53%) |
| Renol Polychem Ltd. | SME | ₹25.77 Cr | ₹105 | ₹99.75 | -5.00% | ₹80.35 (-4.97%) |
| Mehul Colours Ltd. | SME | ₹21.66 Cr | ₹72 | ₹86.03 | +19.49% | ₹68.00 (+1.72%) |
| Patel Chem Specialities Ltd. | SME | ₹58.80 Cr | ₹84 | ₹104.50 | +24.40% | ₹93.83 (+1.39%) |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Investment in Altra Agro-Chem Private Limited, Associate Company, by way of subscription to equity shares for making it Subsidiary | 61.72 |
| 2 | Investment in Altra Pharma-Chem Private Limited, Associate Company, by way of subscription to equity shares for making it Subsidiary | 21.64 |
| 3 | Repayment or pre-payment, in in part or full of certain borrowings availed by the Company from financial institutions | 25.00 |
| 4 | General Corporate Purposes | |
| Total | 108.37 |
| KPI | Dec 31, 2025 | Mar 31, 2025 |
|---|---|---|
| ROE | 18.21% | 12.15% |
| ROCE | 12.68% | 12.54% |
| Debt/Equity | 1.55 | 1.57 |
| RoNW | 17.07% | 11.87% |
| PAT Margin | 1.62% | 0.87% |
| EBITDA Margin | 2.64% | 2.18% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 2.60 | 5.08 |
| Promoter Holding | 98.50% |
Lead Manager Reports
Ujin Pharma IPO is a main-board IPO of 1,91,51,400 equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at To be declared. The minimum order quantity is .
The Ujin Pharma IPO open and close dates are not available as of now.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Ujin Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in Ujin Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Ujin Pharma IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Ujin Pharma IPO dates are not announced. Please check back again after some time.
Ujin Pharma IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in Ujin Pharma IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Ujin Pharma IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Ujin Pharma IPO allotment status.
The Ujin Pharma IPO listing date is not yet announced. The tentative date of listing is .
